The Impact of Exercise on Cardiotoxicity in Pediatric Cancer Survivors: A Scoping Review Protocol

Authors

  • Stephanie Jane Kendall School of Health and Human Performance, Dalhousie University, Halifax NS; Beatrice Hunter Cancer Research Institute, Halifax NS
  • Jodi E Langley School of Health and Human Performance, Dalhousie University, Halifax NS; Beatrice Hunter Cancer Research Institute, Halifax NS
  • Bruce N Crooks Beatrice Hunter Cancer Research Institute, Halifax NS; Department of Pediatrics, IWK Health, Halifax NS
  • Nicholas Giacomantonio Department of Medicine, Division of Cardiology, Nova Scotia Health, Halifax NS
  • Stefan Heinze-Milne Department of Pharmacology, Dalhousie University, Halifax NS
  • Will J Johnston School of Health and Human Performance, Dalhousie University, Halifax NS; Beatrice Hunter Cancer Research Institute, Halifax NS
  • Melanie R Keats School of Health and Human Performance, Dalhousie University, Halifax NS; Beatrice Hunter Cancer Research Institute, Halifax NS; Department of Medicine, Division of Medical Oncology, Nova Scotia Health, Halifax NS
  • Sharon L Mulvagh
  • Scott A Grandy School of Health and Human Performance, Dalhousie University, Halifax NS; Beatrice Hunter Cancer Research Institute, Halifax NS; Department of Medicine, Division of Cardiology, Nova Scotia Health, Halifax NS; Department of Pharmacology, Dalhousie University, Halifax NS; Department of Medicine, Division of Medical Oncology, Nova Scotia Health, Halifax NS

DOI:

https://doi.org/10.15273/hpj.v2i2.11294

Keywords:

pediatric cancer, exercise, cardiotoxicity, adolescent oncology

Abstract

Introduction: Childhood and adolescent cancer survivors treated with anthracyclines and chest-directed radiation therapy have a much higher risk of developing cardiovascular complications into adulthood. Exercise is one intervention that may mitigate some of these adverse treatment-related effects. Nevertheless, efforts to consolidate this evidence are limited, and a review is required to summarize the impact of current exercise interventions on managing cardiac-related side effects of cancer treatments in pediatric cancer survivors.

Objective: This scoping review protocol describes the methods used to explore the current literature characterizing exercise interventions and their reported cardiac-related outcomes for managing cardiotoxicity in childhood and adolescent cancer survivors.

Methods: Joanna Briggs Institute guidelines for conducting and reporting scoping reviews will be followed. Studies considered for this review must include an exercise intervention with cardiac surveillance conducted at two or more time points. Intervention participants must have received a cancer diagnosis ’‰¤19 years of age and received anthracyclines or chest-directed radiation therapy.

Conclusion/Discussion: This scoping review protocol provides extensive details regarding the methods used, will enhance the transparency of reporting, and will improve the quality of the final scoping review manuscript. Outputs from the completed scoping review manuscript will summarize the breadth of literature reporting on exercise interventions used to manage treatment-related cardiotoxicity in childhood and adolescent cancer survivors.

Author Biography

Stephanie Jane Kendall, School of Health and Human Performance, Dalhousie University, Halifax NS; Beatrice Hunter Cancer Research Institute, Halifax NS

Department of Health and Human Performance. MSc Kinesiology Candidate

References

Armenian, S. H., Armstrong, G. T., Aune, G., Chow, E. J., Ehrhardt, M. J., Ky, B., Moslehi, J., Mulrooney, D. A., Nathan, P. C., Ryan, T. D., van der Pal, H. J., van Dalen, E. C., & Kremer, L. C. M. (2018). Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention. Journal of Clinical Oncology, 36(21), 2135–2144. https://doi.org/10.1200/JCO.2017.76.3920

Armenian, S. H., Hudson, M. M., Mulder, R. L., Chen, M. H., Constine, L. S., Dwyer, M., Nathan, P. C., Tissing, W. J. E., Shankar, S., Sieswerda, E., Skinner, R., Steinberger, J., van Dalen, E. C., van der Pal, H., Wallace, W. H., Levitt, G., & Kremer, L. C. M. (2015). Recommendations for Cardiomyopathy Surveillance for Survivors of Childhood Cancer: A Report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. The Lancet. Oncology, 16(3), e123–e136. https://doi.org/10.1016/S1470-2045(14)70409-7

Asselin, B. L., Devidas, M., Chen, L., Franco, V. I., Pullen, J., Borowitz, M. J., Hutchison, R. E., Ravindranath, Y., Armenian, S. H., Camitta, B. M., & Lipshultz, S. E. (2016). Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children‘s Oncology Group Randomized Trial Pediatric Oncology Group 9404. Journal of Clinical Oncology, 34(8), 854–862. https://doi.org/10.1200/JCO.2015.60.8851

Avila, M. S., Siqueira, S. R. R., Ferreira, S. M. A., & Bocchi, E. A. (2019). Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity. Methodist DeBakey Cardiovascular Journal, 15(4), 267–273. https://doi.org/10.14797/mdcj-15-4-267

Awadalla, M., Hassan, M. Z. O., Alvi, R. M., & Neilan, T. G. (2018). Advanced imaging modalities to detect cardiotoxicity. Current Problems in Cancer, 42(4), 386–396. https://doi.org/10.1016/j.currproblcancer.2018.05.005

Bansal, N., Franco, V. I., & Lipshultz, S. E. (2014). Anthracycline cardiotoxicity in survivors of childhood cancer: Clinical course, protection, and treatment. Progress in Pediatric Cardiology, 36(1–2), 11–18. https://doi.org/10.1016/j.ppedcard.2014.09.012

Billinger, S. A., Boyne, P., Coughenour, E., Dunning, K., & Mattlage, A. (2015). Does aerobic exercise and the FITT principle fit into stroke recovery? Current Neurology and Neuroscience Reports, 15(2), Article 519. https://doi.org/10.1007/s11910-014-0519-8

Canadian Agency for Drugs and Technologies in Health. (2019, April). Grey matters: A practical tool for searching health-related grey literature. https://www.cadth.ca/sites/default/files/is/Grey%20Matters_EN-2019.doc

Canadian Cancer Statistics Advisory Committee, Canadian Cancer Society, Statistics Canada, & Public Health Agency of Canada. (2021, November). Canadian cancer statistics 2021. Canadian Cancer Society. https://cancer.ca/Canadian-Cancer-Statistics-2021-EN

Chao, C., Xu, L., Bhatia, S., Cooper, R., Brar, S., Wong, F. L., & Armenian, S. H. (2016). Cardiovascular Disease Risk Profiles in Survivors of Adolescent and Young Adult (AYA) Cancer: The Kaiser Permanente AYA Cancer Survivors Study. Journal of Clinical Oncology, 34(14), 1626–1633. https://doi.org/10.1200/JCO.2015.65.5845

Chicco, A. J., Schneider, C. M., & Hayward, R. (2005). Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 289(2), R424–R431. https://doi.org/10.1152/ajpregu.00636.2004

Chow, E. J., Leger, K. J., Bhatt, N. S., Mulrooney, D. A., Ross, C. J., Aggarwal, S., Bansal, N., Ehrhardt, M. J., Armenian, S. H., Scott, J. M., & Hong, B. (2019). Paediatric cardio-oncology: Epidemiology, screening, prevention, and treatment. Cardiovascular Research, 115(5), 922–934. https://doi.org/10.1093/cvr/cvz031

Eneh, C., & Lekkala, M. R. (2022). Dexrazoxane. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK560559/

Greene, J., & Hennessy, B. (2015). The role of anthracyclines in the treatment of early breast cancer. Journal of Oncology Pharmacy Practice, 21(3), 201–212. https://doi.org/10.1177/1078155214531513

Guo, S., & Wong, S. (2014). Cardiovascular Toxicities from Systemic Breast Cancer Therapy. Frontiers in Oncology, 4, 346. https://doi.org/10.3389/fonc.2014.00346

Hausner, E., Fiszman, M. L., Hanig, J., Harlow, P., Zornberg, G., & Sobel, S. (2008). Long-Term Consequences of Drugs on the Paediatric Cardiovascular System. Drug Safety, 31(12), 1083–1096. https://doi.org/10.2165/0002018-200831120-00005

Hayward, R., Lien, C.-Y., Jensen, B. T., Hydock, D. S., & Schneider, C. M. (2012). Exercise training mitigates anthracycline-induced chronic cardiotoxicity in a juvenile rat model. Pediatric Blood & Cancer, 59(1), 149–154. https://doi.org/10.1002/pbc.23392

Hofmann, U., & Frantz, S. (2013). How can we cure a heart “in flame”? A translational view on inflammation in heart failure. Basic Research in Cardiology, 108(4), 356. https://doi.org/10.1007/s00395-013-0356-y

Huang, T.-T., & Ness, K. K. (2011). Exercise interventions in children with cancer: A review. International Journal of Pediatrics, 2011, Article 461512. https://doi.org/10.1155/2011/461512

Hydock, D. S., Lien, C.-Y., Jensen, B. T., Parry, T. L., Schneider, C. M., & Hayward, R. (2012). Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity. Experimental Biology and Medicine, 237(12), 1483–1492. https://doi.org/10.1258/ebm.2012.012137

Hydock, D. S., Lien, C.-Y., Schneider, C. M., & Hayward, R. (2008). Exercise Preconditioning Protects against Doxorubicin-Induced Cardiac Dysfunction. Medicine & Science in Sports & Exercise, 40(5), 808–817. https://doi.org/10.1249/MSS.0b013e318163744a

Jones, L. W., Fels, D. R., West, M., Allen, J. D., Broadwater, G., Barry, W. T., Wilke, L. G., Masko, E., Douglas, P. S., Dash, R. C., Povsic, T. J., Peppercorn, J., Marcom, P. K., Blackwell, K. L., Kimmick, G., Turkington, T. G., & Dewhirst, M. W. (2013). Modulation of Circulating Angiogenic Factors and Tumor Biology by Aerobic Training in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Cancer Prevention Research, 6(9), 925–937. https://doi.org/10.1158/1940-6207.CAPR-12-0416

Jones, L. W., Liu, Q., Armstrong, G. T., Ness, K. K., Yasui, Y., Devine, K., Tonorezos, E., Soares-Miranda, L., Sklar, C. A., Douglas, P. S., Robison, L. L., & Oeffinger, K. C. (2014). Exercise and Risk of Major Cardiovascular Events in Adult Survivors of Childhood Hodgkin Lymphoma: A Report From the Childhood Cancer Survivor Study. Journal of Clinical Oncology, 32(32), 3643–3650. https://doi.org/10.1200/JCO.2014.56.7511

Keats, M. R., Grandy, S. A., Giacomantonio, N., MacDonald, D., Rajda, M., & Younis, T. (2016). EXercise to prevent AnthrCycline-based Cardio-Toxicity (EXACT) in individuals with breast or hematological cancers: A feasibility study protocol. Pilot and Feasibility Studies, 2, Article 44. https://doi.org/10.1186/s40814-016-0084-9

Kirkham, A. A., Shave, R. E., Bland, K. A., Bovard, J. M., Eves, N. D., Gelmon, K. A., McKenzie, D. C., Virani, S. A., Stöhr, E. J., Warburton, D. E. R., & Campbell, K. L. (2017). Protective effects of acute exercise prior to doxorubicin on cardiac function of breast cancer patients: A proof-of-concept RCT. International Journal of Cardiology, 245, 263–270. https://doi.org/10.1016/j.ijcard.2017.07.037

Kopp, L. M., Womer, R. B., Schwartz, C. L., Ebb, D. H., Franco, V. I., Hall, D., Barkauskas, D. A., Krailo, M. D., Grier, H. E., Meyers, P. A., Wexler, L. H., Marina, N. M., Janeway, K. A., Gorlick, R., Bernstein, M. L., Lipshultz, S. E., & for the Children‘s Oncology Group. (2019). Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: A report from the Children‘s Oncology Group. Cardio-Oncology, 5(1), 15. https://doi.org/10.1186/s40959-019-0050-9

Lipshultz, S. E., Adams, M. J., Colan, S. D., Constine, L. S., Herman, E. H., Hsu, D. T., Hudson, M. M., Kremer, L. C., Landy, D. C., Miller, T. L., Oeffinger, K. C., Rosenthal, D. N., Sable, C. A., Sallan, S. E., Singh, G. K., Steinberger, J.,

Lipshultz, S. E., Landy, D. C., Lopez-Mitnik, G., Lipsitz, S. R., Hinkle, A. S., Constine, L. S., French, C. A., Rovitelli, A. M., Proukou, C., Adams, M. J., & Miller, T. L. (2012). Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy. Journal of Clinical Oncology, 30(10), 1050–1057. https://doi.org/10.1200/JCO.2010.33.7907

Manson, J., Greenland, P., LaCroix, A., Stefanick, M., Mouton, C., Oberman, A., Perri, M., Sheps, D., Pettinger, M., & Siscovick, D. (2002). Walking Compared with Vigorous Exercise for the Prevention of Cardiovascular Events in Women. The New England Journal of Medicine, 347(10), 716–725.

McGowan, J., Sampson, M., Salzwedel, D. M., Cogo, E., Foerster, V., & Lefebvre, C. (2016). PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. Journal of Clinical Epidemiology, 75, 40–46. https://doi.org/10.1016/j.jclinepi.2016.01.021

McGowan, J. V., Chung, R., Maulik, A., Piotrowska, I., Walker, J. M., & Yellon, D. M. (2017). Anthracycline Chemotherapy and Cardiotoxicity. Cardiovascular Drugs and Therapy, 31(1), 63–75. https://doi.org/10.1007/s10557-016-6711-0

Morales, J. S., Valenzuela, P. L., Herrera-Olivares, A. M., Baño-Rodrigo, A., Castillo-Garcà­a, A., Rincón-Castanedo, C., Martà­n-Ruiz, A., San-Juan, A. F., Fiuza-Luces, C., & Lucia, A. (2020). Exercise interventions and cardiovascular health in childhood cancer: A meta-analysis. International Journal of Sports Medicine, 41(3), 141–153. https://doi.org/10.1055/a-1073-8104

Mulrooney, D. A., Yeazel, M. W., Kawashima, T., Mertens, A. C., Mitby, P., Stovall, M., Donaldson, S. S., Green, D. M., Sklar, C. A., Robison, L. L., & Leisenring, W. M. (2009). Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: Retrospective analysis of the childhood cancer survivor study cohort. BMJ (Online), 339(7736), 34. https://doi.org/10.1136/bmj.b4606

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., ”¦ Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372(8286), Article n71. https://doi.org/10.1136/bmj.n71

Peters, M. D. J., Marnie, C., Tricco, A. C., Pollock, D., Munn, Z., Alexander, L., McInerney, P., Godfrey, C. M., & Khalil, H. (2020). Updated methodological guidance for the conduct of scoping reviews. JBI Evidence Synthesis, 18(10), 2119–2126. https://doi.org/10.11124/jbies-20-00167

Reichardt, P., Tabone, M.-D., Mora, J., Morland, B., & Jones, R. L. (2018). Risk–benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: Re-evaluating the European labeling. Future Oncology, 14(25), 2663–2676. http://dx.doi.org/10.2217/fon-2018-0210

Scott, J. M., Khakoo, A., Mackey, J. R., Haykowsky, M. J., Douglas, P. S., & Jones, L. W. (2011). Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer: Current Evidence and Underlying Mechanisms. Circulation, 124(5), 642–650. https://doi.org/10.1161/CIRCULATIONAHA.111.021774

Sun, J., Zhang, J., Yan, W., Chen, C., Wu, G., Abbasi, S., Pham, B., Lee, S., Cheng, J., Memon, N. B., & Xi, Y. (2014). Iloprost prevents doxorubicin mediated human cardiac progenitor cell depletion. International Journal of Cardiology, 176(2), 536–539. https://doi.org/10.1016/j.ijcard.2014.07.031

Tian, D., & Meng, J. (2019). Exercise for Prevention and Relief of Cardiovascular Disease: Prognoses, Mechanisms, and Approaches. Oxidative Medicine and Cellular Longevity, 2019, e3756750. https://doi.org/10.1155/2019/3756750

Tricco, A. C., Lillie, E., Zarin, W., O‘Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., Hempel, S., Akl, E. A., Chang, C., McGowan, J., Stewart, L., Hartling, L., Aldcroft, A., Wilson, M. G., Garritty, C., ”¦ Straus, S. E. (2018). PRISMA extension for Scoping Reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467–473. https://doi.org/10.7326/M18-0850

Tukenova, M., Guibout, C., Oberlin, O., Doyon, F., Mousannif, A., Haddy, N., Guérin, S., Pacquement, H., Aouba, A., Hawkins, M., Winter, D., Bourhis, J., Lefkopoulos, D., Diallo, I., & De Vathaire, F. (2010). Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. Journal of Clinical Oncology, 28(8), 1308–1315. https://doi.org/10.1200/JCO.2008.20.2267

Upshaw, J. N. (2020). Cardioprotective strategies to prevent cancer treatment- related cardiovascular toxicity: A review. Current Oncology Reports, 22(7), Article 72. https://doi.org/10.1007/s11912-020-00923-w

Varghese, S. S., Johnston, W. J., Eekhoudt, C. R., Keats, M. R., Jassal, D. S., & Grandy, S. A.(2021). Exercise to reduce anthracycline-mediated cardiovascular complications in breast cancer survivors. Current Oncology, 28(5), 4139–4156. https://doi.org/10.3390/curroncol28050351

Wogksch, M. D., Goodenough, C. G., Finch, E. R., Partin, R. E., & Ness, K. K. (2021). Physical activity and fitness in childhood cancer survivors: A scoping review. Aging and Cancer, 2(4), 112–128. https://doi.org/10.1002/aac2.12042

Wolf, C. M., Reiner, B., Kühn, A., Hager, A., Müller, J., Meierhofer, C., Oberhoffer, R., Ewert, P., Schmid, I., & Weil, J. (2020). Subclinical Cardiac Dysfunction in Childhood Cancer Survivors on 10-Years Follow-Up Correlates With Cumulative Anthracycline Dose and Is Best Detected by Cardiopulmonary Exercise Testing, Circulating Serum Biomarker, Speckle Tracking Echocardiography, and Tissue Doppler Imaging. Frontiers in Pediatrics, 8, 123. https://doi.org/10.3389/fped.2020.00123

Wurz, A., McLaughlin, E., Lategan, C., Chamorro Viña, C., Grimshaw, S. L., Hamari, L., Götte, M., Kesting, S., Rossi, F., van der Torre, P., Guilcher, G. M. T., McIntyre, K., & Culos-Reed, S. N. (2021). The international Pediatric Oncology Exercise Guidelines (iPOEG). Translational Behavioral Medicine, 11(10), 1915–1922. https://doi.org/10.1093/tbm/ibab028

Wurz, A., McLaughlin, E., Lategan, C., Ellis, K., & Culos-Reed, S. N. (2021). Synthesizing the literature on physical activity among children and adolescents affected by cancer: Evidence for the international Pediatric Oncology Exercise Guidelines (iPOEG). Translational Behavioral Medicine, 11(3), 699–708. https://doi.org/10.1093/tbm/ibaa136

Xu, Z., Zhu, L., Liu, X., Gong, X., Gattrell, W., & Liu, J. (2015). Iloprost for children with pulmonary hypertension after surgery to correct congenital heart disease. Pediatric Pulmonology, 50(6), 588–595. https://doi.org/10.1002/ppul.23032

A bowl of orange-coloured soup with fresh thyme. There is a slice of baguette on the side with a blue and white striped cloth napkin.

Downloads

Published

2022-11-22

Issue

Vol. 2 No. 2 (2022)

Section

Articles

License

Copyright (c) 2022 Stephanie Jane Kendall et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The journal aims to reduce barriers to publishing and sharing research and inequalities to accessing information.This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. The open-access nature of the journal means that there will be no charge for authors or readers to use the journal. The journal has a Creative Commons Attribution Non-Commercial (CCBYNC) attribution which allows the author (and others) to share and distribute their full-text article in other public domains, such as Google Scholar or Research Gate.